SWOG Cancer Research Network: Leukemia, Monocytic, Acute trials
The registry lists 11 Leukemia, Monocytic, Acute studies with SWOG Cancer Research Network as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 2 4Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLCompletedNCT00085709Phase 3Results posted
- S0106B Studying Bone Marrow Samples From Women With Acute Myeloid LeukemiaCompletedNCT01575535
- S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based ChemotherapyCompletedNCT01360125
- S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid LeukemiaCompletedNCT01338974
- S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid LeukemiaCompletedNCT01059734
- S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid LeukemiaCompletedNCT00899743
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid LeukemiaCompletedNCT00899171
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00066794Phase 2
- S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00049179Phase 2
- S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00023777Phase 2
- S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00004217Phase 2